Nothing said here yet.
to join the conversation.
The rapid expansion of its real-world dataset strengthens the foundation of the Company's Chemical Intelligence platform, supporting product improvement, deeper customer engagement and future commercial opportunities.Ongoing factory operations connect…
Partner's Written Confirmation Fulfills Payment Conditions; Initial License Fee Payable Within 15 Business DaysHOUSTON, TX / ACCESS Newswire / September 30, 2026 / (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it has completed the required data delivery and technology transfer under its VELDONA® license agreement, triggering a $600,000 initial license payment.
("ASE") under the announced $2.1 million, three-year agreement.
Ainos expects to complete the agreed contractual delivery shortly, with an initial license fee of $600,000 payable within 15 business days after the applicable payment conditions are satisfied.
("BioPhoenix"), establishing a collaboration framework with a potential aggregate value of $10 million.
Report points to front-end semiconductor orders, a $2.VASRO highlighted two developments that it views as important markers in Ainos' semiconductor commercialization: the transition of its front-end semiconductor program from validation to initial commercial…
Ainos Inc. (NASDAQ:AIMD) shares rose 6.
Ainos is receiving initial commercial orders from a front-end semiconductor company.The milestone marks Ainos' progress toward commercial adoption in front-end semiconductor environments and represents a step toward the broader revenue-generation…
New patents cover electronic nose integration with robotics, expanding Ainos' portfolio of 124 patent assets worldwide across chips, sensing architectures, chemical molecules and real-world applicationsHOUSTON, TX / ACCESS Newswire / September 9, 2026 /…